Qian Yuan, Wang Xuan, Liu Yang, Wang Yunpeng, Li Jianghua, Du Guocheng, Zhao Xinrui, Chen Jian
Science Center for Future Foods, Jiangnan University, 1800 Lihu Road, Wuxi, 214122 Jiangsu China.
Key Laboratory of Industrial Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, 1800 Lihu Road, Wuxi, 214122 Jiangsu China.
3 Biotech. 2025 May;15(5):115. doi: 10.1007/s13205-025-04286-6. Epub 2025 Apr 4.
Myoglobin and hemoglobin are both heme-binding proteins that have widespread applications in food processing and medical treatments. is often chosen to produce heterologous hemoproteins. However, due to the insufficient heme supply, the inactive hemoproteins take a large proportion of synthesized products. To overcome this problem, the intracellular heme supply was increased by improving heme uptake efficiency. At first, an efficient method was created for the screen of potential heme importers from various microorganisms by knocking out gene to obtain a deficient strain X33-Δ- (HEMEX) in heme synthesis. Based on the significantly improved cell growth, two effective heterogenous heme importers (Caflc1 and Shu1) were selected when the exogenous heme was supplemented. Finally, the titers of porcine myoglobin (PMB) and soybean hemoglobin (SHB) increased by 112.28% and 5.78-fold, respectively, through the overexpression of heme importers. The applied strategy provides a promising approach to synthesize other valuable hemoproteins in .
The online version contains supplementary material available at 10.1007/s13205-025-04286-6.
肌红蛋白和血红蛋白都是血红素结合蛋白,在食品加工和医学治疗中有广泛应用。通常选择用于生产异源血红素蛋白。然而,由于血红素供应不足,无活性的血红素蛋白在合成产物中占很大比例。为克服这一问题,通过提高血红素摄取效率来增加细胞内血红素供应。首先,通过敲除基因创建了一种从各种微生物中筛选潜在血红素转运蛋白的有效方法,以获得血红素合成缺陷型菌株X33-Δ-(HEMEX)。基于显著改善的细胞生长,当补充外源血红素时,选择了两种有效的异源血红素转运蛋白(Caflc1和Shu1)。最后,通过血红素转运蛋白的过表达,猪肌红蛋白(PMB)和大豆血红蛋白(SHB)的滴度分别提高了112.28%和5.78倍。所应用的策略为在中合成其他有价值的血红素蛋白提供了一种有前景的方法。
在线版本包含可在10.1007/s13205-025-04286-6获取的补充材料。